CT-based radiomics for prediction of response to neoadjuvant immunochemotherapy in patients with esophageal carcinoma

CT-based radiomics for prediction of response to neoadjuvant immunochemotherapy in patients with esophageal carcinoma

BackgroundIn order to investigate the value of radiomic features derived from enhanced computed tomography (CT) for assessment of therapeutic efficacy in patients with Esophageal squamous cell carcinoma (ESCC) underwent neoadjuvant immunochemotherapy (NICT).MethodsThe primary cohort of this study in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peng Zhao, Xianhe Qiao, Yikang Geng, Yaoyi Yv, Ruiqing Meng, Xiaowei Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Oncology
Subjects:	esophageal carcinoma neoadjuvant therapy (NACT) computer tomography radiomics therapeutic response
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1511691/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01)

A preoperative pathological staging prediction model for esophageal cancer based on CT radiomics
by: Haojun Li, et al.
Published: (2025-02-01)

Effectiveness and Safety of Neoadjuvant Immunochemotherapy with and without Surgery in Patients with Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study
by: Liao X, et al.
Published: (2025-06-01)

Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis
by: Chong-Rui Li, et al.
Published: (2025-07-01)

Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
by: Hai Zhang, et al.
Published: (2025-08-01)

Advances in the use of Radiomics and Pathomics for predicting the efficacy of neoadjuvant therapy in tumors
by: Jiayi Wang, et al.
Published: (2025-08-01)

Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changingCentral Message
by: Stephanie G. Worrell, MD, FACS
Published: (2024-06-01)

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-04-01)

Repeatability and prognostic value of radiomic features: a study in esophageal cancer and nasopharyngeal carcinoma
by: Jie Gong, et al.
Published: (2025-08-01)

A novel framework for esophageal cancer grading: combining CT imaging, radiomics, reproducibility, and deep learning insights
by: Muna Alsallal, et al.
Published: (2025-05-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma
by: Xiaoyang Wang, et al.
Published: (2025-06-01)

Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta‐Analysis
by: Feng Su, et al.
Published: (2025-02-01)

Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma
by: Yajie Mao, et al.
Published: (2025-08-01)

Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer
by: Yilin Chen, et al.
Published: (2025-03-01)

Integrative multimodal ultrasound and radiomics for early prediction of neoadjuvant therapy response in breast cancer: a clinical study
by: Siyu Wang, et al.
Published: (2025-07-01)

Radiomic-based models are able to predict the pathologic response to different neoadjuvant chemotherapy regimens in patients with gastric and gastroesophageal cancer: a cohort study
by: Annamaria Agnes, et al.
Published: (2025-05-01)

Intra- and peritumoral radiomics nomogram based on DCE-MRI for the early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
by: Yun Zhu, et al.
Published: (2025-06-01)

Non-invasive liver fibrosis screening on CT images using radiomics
by: Jay J. Yoo, et al.
Published: (2025-07-01)

Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma
by: Likun Liu, et al.
Published: (2025-08-01)

Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma
by: Guanzhi Ye, et al.
Published: (2025-04-01)

Radiomics of magnetic resonance imaging for assessment of pathological complete response to neoadjuvant therapy and long-term survival in breast cancer
by: N. V. Petrova, et al.
Published: (2023-09-01)

Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
by: Qiaofeng Chen, et al.
Published: (2025-03-01)

Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy
by: Nuo Yu, et al.
Published: (2025-04-01)

Development of a prediction model for chemotherapy and immunotherapy response in esophageal squamous cell carcinoma patients using machine learning algorithms
by: CHEN Jincheng, et al.
Published: (2025-03-01)

DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT
by: Yiyao Sun, et al.
Published: (2025-04-01)

A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study
by: Jie Gong, et al.
Published: (2024-12-01)

Personalized predictions of neoadjuvant chemotherapy response in breast cancer using machine learning and full-field digital mammography radiomics
by: Ye Ruan, et al.
Published: (2025-04-01)

Role of Pelvic Ultrasound in Predicting the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
by: Giorgia Perniola, et al.
Published: (2025-02-01)

EFFICACY OF COMBINED MODALITY TREATMENT INCLUDING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER
by: Yu. V. Rudyk, et al.
Published: (2016-02-01)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study
by: Qi Zhao, et al.
Published: (2025-08-01)

Proteomic alterations in ovarian cancer—Predicting residual disease status using artificial intelligence and SHAP-based biomarker interpretation
by: Seyma Yasar, et al.
Published: (2025-07-01)

CT Radiomics Nomogram Prediction for Tumor Deposits and Prognosis in Colorectal Cancer
by: Manman LI, et al.
Published: (2025-07-01)

CT-based radiomics model to predict platinum sensitivity in epithelial ovarian carcinoma: a multicentre study
by: Mengge He, et al.
Published: (2025-07-01)

CT manifestations of primary esophageal tuberculosis
by: Zhong Huang, et al.
Published: (2025-04-01)

The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study
by: Xue Wu, et al.
Published: (2025-05-01)

Recurrence patterns and long-term survival of locally advanced esophageal cancer patients with pathological complete response after different neoadjuvant therapies followed by surgery
by: Jiwei Wu, et al.
Published: (2025-07-01)

Developing a machine-learning model to enable treatment selection for neoadjuvant chemotherapy for esophageal cancer
by: Yutaka Miyawaki, et al.
Published: (2025-07-01)

Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis
by: Ziqian Zhao, et al.
Published: (2025-08-01)

Dual energy CT-derived quantitative parameters and hematological characteristics predict pathological complete response in neoadjuvant chemoradiotherapy esophageal squamous cell carcinoma patients
by: Miaomiao Li, et al.
Published: (2025-05-01)